Ticker

Analyst Price Targets — CCAP

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 17, 2026 7:24 amPiper Sandler$12.00$11.15StreetInsider Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
August 12, 2026 10:22 amFinian O'SheaWells Fargo$11.00$11.44TheFly Crescent Capital BDC price target lowered to $11 from $12 at Wells Fargo
May 15, 2026 10:54 amFinian O'SheaWells Fargo$12.00$11.99TheFly Crescent Capital BDC price target lowered to $12 from $13 at Wells Fargo
May 15, 2026 12:45 amOppenheimer$16.00$11.99TheFly Crescent Capital BDC downgraded to Perform from Outperform at Oppenheimer
February 26, 2026 9:05 pmRobert DoddRaymond James$14.00$13.22StreetInsider Crescent BDC (CCAP) PT Lowered to $14 at Raymond James
May 16, 2025 10:14 amFinian O'SheaWells Fargo$15.00$15.42TheFly Crescent Capital BDC price target lowered to $15 from $16 at Wells Fargo
May 13, 2024 6:45 amFinian O'SheaWells Fargo$18.00$18.19TheFly Crescent Capital BDC price target raised to $18 from $16.50 at Wells Fargo
May 10, 2024 9:59 amRobert DoddRaymond James$19.00$18.19TheFly Crescent Capital BDC price target raised to $19 from $18 at Raymond James
April 25, 2022 8:42 amWells Fargo$18.50$17.80Benzinga Wells Fargo Maintains Overweight on Crescent Capital BDC, Lowers Price Target to $18.5

Latest News for CCAP

Crescent Capital BDC: Cheap For Good Reason, Still A Hold

Crescent Capital BDC is rated HOLD, with the stock trading at a record 0.600x NAV and an attractive 12.7% yield. The dividend was reset 19% lower to $0.34, now conservatively covered by NII at 1.06x, and management permanently cut fees. Portfolio credit quality remains pressured: NAV has declined for eight straight quarters, non-accruals are 4.8%, and the watch list is 14.7%.

Seeking Alpha • Aug 31, 2026
Crescent Capital Group Closes Second CLO Equity Fund at $232 Million

LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP (“Crescent”), one of the leading alternative credit investment firms, announced today the final close of its second captive collateralized loan obligation (CLO) equity fund, Crescent CLO Equity Funding II, with $232 million in commitments. The fund doubled the size of its predecessor, Crescent CLO Equity Funding I, which closed in 2018 with $103 million in…

Business Wire • Aug 27, 2026
Crescent Capital BDC: I'm Much Less Optimistic Than Wall Street

CCAP cut its dividend by 19% a few months ago. But I expect another dividend cut, as I see several signals of struggling NII. NII dropped nearly 22% year-over-year to $0.36 per share, leaving only a 6% margin of safety over the current base dividend and heightening payout risk.

Seeking Alpha • Aug 12, 2026
Crescent Capital BDC Q2 Earnings Call Highlights

Crescent Capital BDC NASDAQ: CCAP reported second-quarter net investment income of $0.36 per share, exceeding its $0.34 per-share base dividend but declining from $0.38 per share in the prior quarter excluding a one-time incentive-fee waiver.

MarketBeat • Aug 11, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CCAP.

No House trades found for CCAP.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top